Literature DB >> 7094199

Repair of DNA interstrand crosslinks after busulphan. A possible mode of resistance.

P Bedford, B W Fox.   

Abstract

The technique of alkaline elution has been used to study the interaction between the antineoplastic drug busulphan and the DNA of cells derived from the transplantable rodent Yoshida sarcoma. A dose-dependent proteinase-resistant filter retention was observed after drug treatment, which indicated the presence of DNA interstrand cross-links. Such cross-links were removed after 6 h in cells resistant to busulphan but not in the busulphan-sensitive parent cells, even after 24 h. Such temporal differences in DNA cross-linking could be correlated with cell survival and also with the level of anaphase chromosome aberrations, which was found to be four-fold higher in the sensitive line than in the resistant line.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7094199     DOI: 10.1007/BF00292863

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  16 in total

1.  Fractionation of DNA from mammalian cells by alkaline elution.

Authors:  K W Kohn; L C Erickson; R A Ewig; C A Friedman
Journal:  Biochemistry       Date:  1976-10-19       Impact factor: 3.162

2.  Differences in the response of leukaemia cells in tissue culture to nitrogen mustard and to dimethyl myleran.

Authors:  P ALEXANDER; Z B MIKULSKI
Journal:  Biochem Pharmacol       Date:  1961-02       Impact factor: 5.858

3.  Myleran in chronic myeloid leukaemia; results of treatment.

Authors:  D A GALTON
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

4.  Myleran in chronic myeloid leukaemia; chemical constitution and biological action.

Authors:  A HADDOW; G M TIMMIS
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

5.  Cross-link repair in human cells and its possible defect in Fanconi's anemia cells.

Authors:  Y Fujiwara; M Tatsumi
Journal:  J Mol Biol       Date:  1977-07-15       Impact factor: 5.469

6.  The letal action of monofunctional and bifunctional alkylating agents on T7 coliphage.

Authors:  W G Verly; L Brakier
Journal:  Biochim Biophys Acta       Date:  1969-02-18

7.  DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.

Authors:  L A Zwelling; S Michaels; H Schwartz; P P Dobson; K W Kohn
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

8.  DNA repair in a Fanconi's anemia fibroblast cell strain.

Authors:  A J Fornace; J B Little; R R Weichselbaum
Journal:  Biochim Biophys Acta       Date:  1979-01-26

9.  The role of formaldehyde in methylene dimethanesulphonate-induced DNA cross-links and its relevance to cytotoxicity.

Authors:  P Bedford; B W Fox
Journal:  Chem Biol Interact       Date:  1981-12       Impact factor: 5.192

10.  Crosslinking of DNA by busulfan. Formation of diguanyl derivatives.

Authors:  W P Tong; D B Ludlum
Journal:  Biochim Biophys Acta       Date:  1980-06-27
View more
  10 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Benzamide potentiation of the cytotoxicity of bifunctional galactitol [correction of galacticol] in resistant P388 leukemia correlates with inhibition of DNA ligase II.

Authors:  E Institoris; B W Fox; I Pályi
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro.

Authors:  A T McGown; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Cross-linking between histones and DNA following treatment with a series of dimethane sulphonate esters.

Authors:  J A Hartley; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 5.  Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesis.

Authors:  D J Stewart; G P Raaphorst; J Yau; A R Beaubien
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

6.  Macromolecular DNA-damage in murine and human leukemic and lymphoid cells after in vitro exposure to ASTA Z 7557 (INN mafosfamide).

Authors:  R Osieka; R Pannenbäcker; C G Schmidt
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

Review 7.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01

8.  Comparative studies of DNA cross-linking reactions following methylene dimethanesulphonate and its hydrolytic product, formaldehyde.

Authors:  P M O'Connor; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  Busulfan therapy of central nervous system xenografts in athymic mice.

Authors:  R H Aaron; G B Elion; O M Colvin; M Graham; S Keir; D D Bigner; H S Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 10.  Multidrug resistance (mdr) genes in human cancer.

Authors:  K Nooter; H Herweijer
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.